Vitamin D: Metaanalyse zur Langzeitsicherheit

Diese Metaanalyse zu „Vitamin D: Metaanalyse zur Langzeitsicherheit“ bündelt Originalarbeiten und ordnet deren Aussagekraft sowie Grenzen ein.

Welche Frage wurde untersucht?

Die Arbeit „Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis“ prüft, wie Vitamin-D-Status oder Supplementierung mit dem im Titel bezeichneten Endpunkt zusammenhängen. Entscheidend ist die Ebene der Evidenz: Hier wird nicht eine einzelne Beobachtung, sondern eine systematisch zusammengeführte Studienlage betrachtet.

Wie wurde die Evidenz zusammengeführt?

Die Review- oder Metaanalyse bezieht 48 unmittelbar eingeschlossene Originalarbeiten ein. Diese Originalarbeiten stehen vollständig in der Quellenliste. Die Zusammenführung erhöht die Datenbasis, beseitigt aber Unterschiede bei Population, Ausgangsstatus, Vergleich, Dosisregime und Endpunktdefinition nicht.

Was zeigt der Gesamtbefund?

Langzeitstudien zeigten häufiger Hyperkalzämie und Hyperkalziurie unter Vitamin D, während Nierensteine nicht signifikant zunahmen.

Der Befund beschreibt genau den untersuchten Vergleich. Er darf nicht als allgemeines Wirkversprechen für Vitamin D oder als Empfehlung für eine bestimmte Einnahmemenge gelesen werden.

Wie belastbar ist das Ergebnis?

Die Analyse konnte keine einfache Dosis-Wirkungs-Regel ableiten und fordert weitere große Langzeitstudien. Metaanalysen übernehmen zudem die Grenzen ihrer eingeschlossenen Studien. Heterogenität, Bias und unterschiedliche Messweisen können einen gepoolten Wert beeinflussen.

Einordnung für Supplement Stack

Der Artikel dokumentiert die gemeinsam ausgewertete Studienlage samt Originalquellen. Die stoffweite Einordnung zu Versorgung, Referenzwerten und Sicherheit steht im Vitamin D: Warum Sonne, Knochen und Calcium zusammengehören.

Fazit

Langzeitstudien zeigten häufiger Hyperkalzämie und Hyperkalziurie unter Vitamin D, während Nierensteine nicht signifikant zunahmen. Für die praktische Einordnung bleibt die genannte Grenze wesentlich: Die Analyse konnte keine einfache Dosis-Wirkungs-Regel ableiten und fordert weitere große Langzeitstudien.

Quellen

  1. Mose et al. (2014). Cardiovascular effects of cholecalciferol treatment in dialysis patients–a randomized controlled trial. BMC Nephrol. DOI: 10.1186/1471-2369-15-50. PMID: 24661355.
  2. Reddy et al. (2013). Double blind randomized control study of intramuscular vitamin D3 supplementation in tropical calcific pancreatitis. Calcif Tissue Int. DOI: 10.1007/s00223-013-9726-6. PMID: 23564348.
  3. Lappe et al. (2007). Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. DOI: 10.1093/ajcn/85.6.1586. PMID: 17556697.
  4. Arora et al. (2015). Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. DOI: 10.1161/circulationaha.114.011732. PMID: 25359163.
  5. Schleithoff et al. (2006). Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.. Am J Clin Nutr. DOI: 10.1093/ajcn/83.4.754. PMID: 16600924.
  6. Steffensen et al. (2011). Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol. DOI: 10.1007/s00415-011-5980-6. PMID: 21400196.
  7. Li et al. (2014). Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trial. PLoS One. DOI: 10.1371/journal.pone.0109998. PMID: 25296334.
  8. Aloia et al. (2008). Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. DOI: 10.1093/ajcn/87.6.1952. PMID: 18541590.
  9. Björkman et al. (2008). Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing. DOI: 10.1093/ageing/afm141. PMID: 17965037.
  10. Dawson-Hughes et al. (1991). Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med. DOI: 10.7326/0003-4819-115-7-505. PMID: 1883119.
  11. Gallagher et al. (2012). Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. DOI: 10.7326/0003-4819-156-6-201203200-00005. PMID: 22431675.
  12. Wepner et al. (2014). Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain. DOI: 10.1016/j.pain.2013.10.002. PMID: 24438771.
  13. Malihi et al. (2016). Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis. The American Journal of Clinical Nutrition. DOI: 10.3945/ajcn.116.134981. PMID: 27604776.
  14. Aloia et al. (2013). Calcium and vitamin D supplementation in postmenopausal women. J Clin Endocrinol Metab. DOI: 10.1210/jc.2013-2121. PMID: 24064695.
  15. Sollid et al. (2014). No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care. DOI: 10.2337/dc14-0218. PMID: 24947792.
  16. Tran et al. (2012). Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia. J Clin Endocrinol Metab. DOI: 10.1210/jc.2012-2682. PMID: 23066119.
  17. Krul-Poel et al. (2014). Study protocol: a randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2 Diabetes Mellitus SUNNY trial. BMC Endocr Disord. DOI: 10.1186/1472-6823-14-59. PMID: 25033925.
  18. Lagari et al. (2012). Differences in vitamin D3 dosing regimens in a geriatric community-dwelling population. Endocr Pract. DOI: 10.4158/ep12081.or. PMID: 22784845.
  19. Baron et al. (2015). A trial of calcium and vitamin D for the prevention of colorectal adenomas.. N Engl J Med. DOI: 10.1056/nejmoa1500409. PMID: 26465985.
  20. Dawson-Hughes et al. (1995). Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr. DOI: 10.1093/ajcn/61.5.1140.
  21. Law et al. (2006). Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing. DOI: 10.1093/ageing/afj080. PMID: 16641143.
  22. Corless et al. (1985). Do vitamin D supplements improve the physical capabilities of elderly hospital patients?. Age Ageing. DOI: 10.1093/ageing/14.2.76. PMID: 4003187.
  23. Grant et al. (2005). Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. DOI: 10.1016/s0140-6736(05)63013-9. PMID: 15885294.
  24. Wood et al. (2014). A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?. Osteoporos Int. DOI: 10.1007/s00198-013-2473-8. PMID: 23982800.
  25. Wissing et al. (2005). A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation. DOI: 10.1097/01.tp.0000149322.70295.a5. PMID: 15714177.
  26. McAlindon et al. (2013). Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. DOI: 10.1001/jama.2012.164487. PMID: 23299607.
  27. Wamberg et al. (2013). Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med. DOI: 10.1016/j.ejim.2013.03.005. PMID: 23566943.
  28. Sneve et al. (2008). Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol. DOI: 10.1530/eje-08-0339. PMID: 19056900.
  29. Lehouck et al. (2012). High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial.. Ann Intern Med. DOI: 10.7326/0003-4819-156-2-201201170-00004. PMID: 22250141.
  30. Goswami et al. (2012). Skeletal muscle strength in young asian indian females after vitamin D and calcium supplementation: a double-blind randomized controlled clinical trial. J Clin Endocrinol Metab. DOI: 10.1210/jc.2012-2340. PMID: 22904178.
  31. Suzuki et al. (2013). Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. DOI: 10.3945/ajcn.112.051664. PMID: 23485413.
  32. Aloia et al. (2005). A randomized controlled trial of vitamin D-3 supplementation in African American women. Arch Intern Med. DOI: 10.1001/archinte.165.14.1618. PMID: 16043680.
  33. Witham et al. (2013). Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial.. JAMA Intern Med. DOI: 10.1001/jamainternmed.2013.9043. PMID: 23939263.
  34. Brohult et al. (1973). Effects of large doses of calciferol on patients with rheumatoid arthritis. A double-blind clinical trial. Scand J Rheumatol. DOI: 10.3109/03009747309097085. PMID: 4129296.
  35. Rastelli et al. (2011). Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat. DOI: 10.1007/s10549-011-1644-6. PMID: 21691817.
  36. Ooms et al. (1995). Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab. DOI: 10.1210/jcem.80.4.7714065. PMID: 7714065.
  37. Witham et al. (2013). Effects of vitamin D supplementation on markers of vascular function after myocardial infarction–a randomised controlled trial. Int J Cardiol. DOI: 10.1016/j.ijcard.2012.03.054. PMID: 22459388.
  38. Abou-Raya et al. (2013). The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol. DOI: 10.3899/jrheum.111594. PMID: 23204220.
  39. Jorde et al. (2009). Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. DOI: 10.1007/s00394-009-0020-3. PMID: 19370371.
  40. Kjærgaard et al. (2012). Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry. DOI: 10.1192/bjp.bp.111.104349. PMID: 22790678.
  41. Prince et al. (2008). Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. DOI: 10.1001/archinternmed.2007.31. PMID: 18195202.
  42. Turner et al. (2014). A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. Am J Obstet Gynecol. DOI: 10.1016/j.ajog.2014.06.023. PMID: 24949544.
  43. Hewitt et al. (2013). Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol. DOI: 10.2215/cjn.02840312. PMID: 23493381.
  44. Zhu et al. (2008). Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab. DOI: 10.1210/jc.2007-1466. PMID: 18089701.
  45. Bolland et al. (2013). Randomised controlled trial of vitamin D supplementation in sarcoidosis. BMJ Open. DOI: 10.1136/bmjopen-2013-003562. PMID: 24157819.
  46. Gallagher et al. (2014). Vitamin D supplementation in young white and African American women. J Bone Miner Res. DOI: 10.1002/jbmr.2010. PMID: 23761326.
  47. Garg et al. (2015). Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study. Endocr Connect. DOI: 10.1530/ec-15-0001. PMID: 25921345.
  48. Amrein et al. (2012). Correction of vitamin D deficiency in critically ill patients - VITdAL@ICU study protocol of a double-blind, placebo-controlled randomized clinical trial. BMC Endocr Disord. DOI: 10.1186/1472-6823-12-27. PMID: 23134762.
  49. Johnson et al. (1980). Prophylactic vitamin D in the elderly. Age Ageing. DOI: 10.1093/ageing/9.2.121. PMID: 7395656.